Ching Ching Leow is currently the VP and Head of Clinical for Lilly Oncology, a role they began in 2023. They previously served as Associate Vice President at Eli Lilly and Company from 2017 to 2021, specializing in immuno-oncology clinical development. They held various positions at AstraZeneca from 2008 to 2016, including Translational Science Lead in Oncology. Ching Ching earned their PhD in Molecular and Medical Genetics and Developmental Biology from the University of Toronto, where their academic journey began in 1996 and continues today.
This person is not in the org chart
This person is not in any teams
This person is not in any offices